Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bi-Cheng Liu

Showing results (161-170 of 269) with videos related to

Pageof 27
Sort By:
Clinical Nephrology|April 24, 2014
Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal diseaseKun Ling Ma, Jing Liu, Min Gao, et al.
The International Journal of Biochemistry & Cell Biology|February 26, 2018
mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKIYi Wen, Yi-Ran Liu, Tao-Tao Tang, et al.
Plos One|December 19, 2013
Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized ratsJun-Feng Chen, Hong Liu, Hai-Feng Ni, et al.
International Journal of Medical Sciences|November 24, 2016
Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal DiseaseZe Bo Hu, Yan Chen, Yu Xiang Gong, et al.
Pharmaceutical Medicine|April 4, 2024
Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee MeetingsFeng Sun, Alexander Bedenkov, Bi-Cheng Liu, et al.
Renal Failure|July 16, 2013
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized ratsHai-Feng Ni, Jun-Feng Chen, Ming-Hui Zhang, et al.
The International Journal of Biochemistry & Cell Biology|January 28, 2015
Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver diseaseJing Liu, Kun Ling Ma, Yang Zhang, et al.
Acta Physiologica (Oxford, England)|February 27, 2024
Mitochondrial fumarate promotes ischemia/reperfusion-induced tubular injuryZuo-Lin Li, Ming-Min Huang, Meng-Yao Yu, et al.
Acta Pharmacologica Sinica|November 18, 2018
Platelet microparticles contribute to aortic vascular endothelial injury in diabetes via the mTORC1 pathwayGui-Hua Wang, Kun-Ling Ma, Yang Zhang, et al.
Cell Death & Disease|March 4, 2018
Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activationTao-Tao Tang, Lin-Li Lv, Ming-Ming Pan, et al.
Pageof 27

Showing results (161-170 of 269) with videos related to

Sort By:
Pageof 27
Clinical Nephrology|April 24, 2014
Activation of mTOR contributes to foam cell formation in the radial arteries of patients with end-stage renal diseaseKun Ling Ma, Jing Liu, Min Gao, et al.
The International Journal of Biochemistry & Cell Biology|February 26, 2018
mROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKIYi Wen, Yi-Ran Liu, Tao-Tao Tang, et al.
Plos One|December 19, 2013
Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized ratsJun-Feng Chen, Hong Liu, Hai-Feng Ni, et al.
International Journal of Medical Sciences|November 24, 2016
Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal DiseaseZe Bo Hu, Yan Chen, Yu Xiang Gong, et al.
Pharmaceutical Medicine|April 4, 2024
Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee MeetingsFeng Sun, Alexander Bedenkov, Bi-Cheng Liu, et al.
Renal Failure|July 16, 2013
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized ratsHai-Feng Ni, Jun-Feng Chen, Ming-Hui Zhang, et al.
The International Journal of Biochemistry & Cell Biology|January 28, 2015
Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver diseaseJing Liu, Kun Ling Ma, Yang Zhang, et al.
Acta Physiologica (Oxford, England)|February 27, 2024
Mitochondrial fumarate promotes ischemia/reperfusion-induced tubular injuryZuo-Lin Li, Ming-Min Huang, Meng-Yao Yu, et al.
Acta Pharmacologica Sinica|November 18, 2018
Platelet microparticles contribute to aortic vascular endothelial injury in diabetes via the mTORC1 pathwayGui-Hua Wang, Kun-Ling Ma, Yang Zhang, et al.
Cell Death & Disease|March 4, 2018
Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activationTao-Tao Tang, Lin-Li Lv, Ming-Ming Pan, et al.
Pageof 27